InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Other Non-Current Liabilities (2016 - 2026)

InflaRx's (IFRX) quarterly Other Non-Current Liabilities came in at $42864.4 in Q2 2026, up 2.69% year-over-year from $41743.3 in Q2 2025, and down 0.72% quarter-over-quarter from $43173.6 in Q1 2026.

Analysis

InflaRx (IFRX) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends

InflaRx has disclosed Other Non-Current Liabilities across 11 years of filings, most recently posting $42864.4 for Q2 2026.

  • In Q2 2026, Other Non-Current Liabilities rose 2.69% year-over-year to $42864.4; the TTM figure through Jun 2026 stood at $42864.4 (up 2.69% YoY), while the FY2025 annual figure was $41664.0, up 5.73% from the prior year.
  • Other Non-Current Liabilities came in at $42864.4 for Q2 2026 at InflaRx, down from $43173.6 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $43173.6 in Q1 2026 to a low of $37623.7 in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $40551.7, with a median of $40150.1 recorded in 2023.
  • Year-over-year, Other Non-Current Liabilities dropped 6.08% in 2022 and rose 11.3% in 2026.
  • Over 5 years, Other Non-Current Liabilities stood at $37623.7 in 2022, then climbed by 5.46% to $39677.4 in 2023, then dropped by 0.68% to $39406.6 in 2024, then increased by 8.93% to $42926.4 in 2025, then dropped by 0.14% to $42864.4 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $42864.4 in Q2 2026, $43173.6 in Q1 2026, and $42926.4 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42,864.42
Mar 31, 2026 43,173.59
Dec 31, 2025 42,926.43
Sep 30, 2025 43,111.24
Jun 30, 2025 41,743.28
Mar 31, 2025 38,790.34
Dec 31, 2024 39,406.59
Sep 30, 2024 40,499.04
Jun 30, 2024 39,712.38
Mar 31, 2024 40,061.76
Dec 31, 2023 39,677.44
Sep 30, 2023 40,143.95
Jun 30, 2023 40,156.26
Mar 31, 2023 39,581.63
Dec 31, 2022 37,623.66
Sep 30, 2022 40,208.97
Jun 30, 2022 40,263.25
Mar 31, 2022 39,986.65
Dec 31, 2021 40,060.72
Sep 30, 2021 41,003.82